Bupropion hydrochloride
- Product NDC
- 68788-8272
- 11-digit product format
- 687888272
- Labeler code
- 68788
- Product ID
- 68788-8272_7e04cd67-41b6-472d-8751-271e0b5ccd57
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA211020
- Marketing category
- ANDA
- Marketing start
- 2022-10-13
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-8272-1 | 68788827201 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8272-1) | 2022-10-13 | 0000-00-00 | No | No | Current |
| 68788-8272-3 | 68788827203 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8272-3) | 2022-10-13 | 0000-00-00 | No | No | Current |
| 68788-8272-6 | 68788827206 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8272-6) | 2022-10-13 | 0000-00-00 | No | No | Current |
| 68788-8272-8 | 68788827208 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8272-8) | 2022-10-13 | 0000-00-00 | No | No | Current |
| 68788-8272-9 | 68788827209 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8272-9) | 2022-10-13 | 0000-00-00 | No | No | Current |